TVTX logo

Travere Therapeutics, Inc. (TVTX) Long term debt

Annual long term debt:

$327.50M-$72.37M(-18.10%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual long term debt is $327.50 million, with the most recent change of -$72.37 million (-18.10%) on December 31, 2024.
  • During the last 3 years, TVTX annual long term debt has risen by +$69.42 million (+26.90%).
  • TVTX annual long term debt is now -18.75% below its all-time high of $403.06 million, reached on December 31, 2022.

Performance

TVTX Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Quarterly long term debt:

$325.14M-$1.10M(-0.34%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly long term debt is $325.14 million, with the most recent change of -$1.10 million (-0.34%) on June 30, 2025.
  • Over the past year, TVTX quarterly long term debt has dropped by -$72.92 million (-18.32%).
  • TVTX quarterly long term debt is now -19.67% below its all-time high of $404.77 million, reached on March 31, 2022.

Performance

TVTX Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

TVTX Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-18.1%-18.3%
3 y3 years+26.9%-19.5%
5 y5 years+54.3%+49.9%

TVTX Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.8%+26.9%-19.5%at low
5 y5-year-18.8%+54.3%-19.7%+49.9%
alltimeall time-18.8%>+9999.0%-19.7%>+9999.0%

TVTX Long term debt History

DateAnnualQuarterly
Jun 2025
-
$325.14M(-0.3%)
Mar 2025
-
$326.25M(-0.4%)
Dec 2024
$327.50M(-18.1%)
$327.50M(-0.3%)
Sep 2024
-
$328.54M(-17.5%)
Jun 2024
-
$398.06M(-0.2%)
Mar 2024
-
$398.98M(-0.2%)
Dec 2023
$399.88M(-0.8%)
$399.88M(-0.2%)
Sep 2023
-
$400.70M(-0.2%)
Jun 2023
-
$401.51M(-0.2%)
Mar 2023
-
$402.30M(-0.2%)
Dec 2022
$403.06M(+56.2%)
$403.06M(-0.1%)
Sep 2022
-
$403.38M(-0.2%)
Jun 2022
-
$404.05M(-0.2%)
Mar 2022
-
$404.77M(+56.8%)
Dec 2021
$258.08M(+5.9%)
$258.08M(+0.7%)
Sep 2021
-
$256.20M(+1.0%)
Jun 2021
-
$253.78M(+1.8%)
Mar 2021
-
$249.28M(+2.3%)
Dec 2020
$243.68M(+14.8%)
$243.68M(+1.3%)
Sep 2020
-
$240.57M(+10.9%)
Jun 2020
-
$216.90M(+4.6%)
Mar 2020
-
$207.41M(-2.3%)
Dec 2019
$212.25M(+8.8%)
$212.25M(+1.0%)
Sep 2019
-
$210.16M(+1.0%)
Jun 2019
-
$208.14M(+0.9%)
Mar 2019
-
$206.36M(+5.8%)
Dec 2018
$195.09M(+332.8%)
$195.09M(+1.2%)
Sep 2018
-
$192.75M(>+9900.0%)
Jun 2018
-
$0.00(-100.0%)
Mar 2018
-
$45.24M(+0.4%)
Dec 2017
$45.08M
$45.08M(+0.4%)
Sep 2017
-
$44.91M(+0.4%)
Jun 2017
-
$44.75M(+0.4%)
DateAnnualQuarterly
Mar 2017
-
$44.58M(+0.4%)
Dec 2016
$44.42M(+1.2%)
$44.42M(+0.4%)
Sep 2016
-
$44.26M(+0.4%)
Jun 2016
-
$44.09M(+0.4%)
Mar 2016
-
$43.93M(+0.1%)
Dec 2015
$43.90M(+1.4%)
$43.90M(+0.4%)
Sep 2015
-
$43.75M(+0.4%)
Jun 2015
-
$43.59M(-48.3%)
Mar 2015
-
$84.24M(+94.6%)
Dec 2014
$43.29M(>+9900.0%)
$43.29M(-48.0%)
Sep 2014
-
$83.29M(+0.6%)
Jun 2014
-
$82.81M(>+9900.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
Nov 2011
-
$0.00(0.0%)
Aug 2011
-
$0.00(0.0%)
May 2011
-
$0.00(0.0%)
Feb 2011
$0.00(0.0%)
$0.00(0.0%)
Nov 2010
-
$0.00(0.0%)
Aug 2010
-
$0.00(0.0%)
May 2010
-
$0.00(0.0%)
Feb 2010
$0.00(-100.0%)
$0.00(0.0%)
Nov 2009
-
$0.00(-100.0%)
Aug 2009
-
$10.40K(+42.5%)
May 2009
-
$7300.00(+73.8%)
Feb 2009
$4200.00(>+9900.0%)
$4200.00(+320.0%)
Nov 2008
-
$1000.00(>+9900.0%)
Aug 2008
-
$0.00(0.0%)
May 2008
-
$0.00
Feb 2008
$0.00
-

FAQ

  • What is Travere Therapeutics, Inc. annual long term debt?
  • What is the all time high annual long term debt for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual long term debt year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly long term debt?
  • What is the all time high quarterly long term debt for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly long term debt year-on-year change?

What is Travere Therapeutics, Inc. annual long term debt?

The current annual long term debt of TVTX is $327.50M

What is the all time high annual long term debt for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual long term debt is $403.06M

What is Travere Therapeutics, Inc. annual long term debt year-on-year change?

Over the past year, TVTX annual long term debt has changed by -$72.37M (-18.10%)

What is Travere Therapeutics, Inc. quarterly long term debt?

The current quarterly long term debt of TVTX is $325.14M

What is the all time high quarterly long term debt for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly long term debt is $404.77M

What is Travere Therapeutics, Inc. quarterly long term debt year-on-year change?

Over the past year, TVTX quarterly long term debt has changed by -$72.92M (-18.32%)
On this page